Clinical Trial Update: Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of methoxyamine and fludarabine phosphate in adults with relapsed or refractory hematologic malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma
• Chronic Lymphocytic Leukemia
• Diffuse Large B-cell Lymphoma
• Extranodal Nk T-cell Lymphoma Nasal Type
• Follicular Lymphoma
• Hodgkin Lymphoma
• Mantle Cell Lymphoma
• Peripheral T-cell Lymphoma

Drugs mentioned

• Fludarabine phosphate (Fludarabine phosphate)
• Methoxyamine (methoxyamine)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma | Phase 1 | Status: COMPLETED